ArticleBMJ case reports2021

Pembrolizumab as adjuvant therapy in a patient with Lynch syndrome with synchronous mixed clear cell carcinoma of ovarian origin and endometroid endometrial carcinoma.

Kathleen Batty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.